Use of In-Hospital Continuous Subcutaneous Insulin Infusion: A Consensus Statement
In the report, the panel identified contraindications to self-management with CSII while in the hospital. Photo courtesy of Medtronic.
There is a lack of transparency throughout the insulin supply chain. It is unclear precisely how the dollars flow and how much each intermediary profits.
Treatment strategies targeting hypertension, hyperlipidemia, and hyperglycemia may improve outcomes in patients with type 2 diabetes.
Further research is needed on whether high 25(OH)D might prevent type 2 diabetes or transition of prediabetes to diabetes.